Suppr超能文献

肾单位耗竭症患儿经历艰难病程和 6 个月全肠外营养后包裹性腹膜硬化症的临床改善:病例报告。

Clinical improvement of encapsulating peritoneal sclerosis after challenging course and 6 months of total parenteral nutrition in child with nephronophthisis: a case report.

机构信息

Pediatric Nephrology Section, Children Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

J Med Case Rep. 2021 Jul 13;15(1):366. doi: 10.1186/s13256-021-02905-3.

Abstract

BACKGROUND

Encapsulating peritoneal sclerosis is a rare but potentially lethal complication of long-term peritoneal dialysis that is associated with significant morbidity and mortality. The occurrence of encapsulating peritoneal sclerosis varies worldwide, but is increased in patients maintained on peritoneal dialysis for 5-8 years. The etiology of encapsulating peritoneal sclerosis remains unidentified, and a high index of clinical suspicion is required for diagnosis.

CASE PRESENTATION

We report a 5-year-old Saudi female with end-stage renal disease secondary to nephronophthisis type 2. She underwent peritoneal dialysis for 30 months, with four episodes of peritonitis. She presented with clinical signs of peritonitis. Three days later, she developed septic shock, which required pediatric intensive care unit admission. The peritoneal dialysis catheter was removed because of refractory peritonitis. Her course was complicated by small bowel perforation, and severe adhesions were revealed on abdominal ultrasound and computed tomography, consistent with a diagnosis of EPS. This finding was later confirmed by diagnostic laparotomy performed twice and complicated by recurrent abdominal wall fistula. She received total parenteral nutrition for 6 months and several courses of antibiotics. The patient received supportive treatment including nutritional optimization and treatment for infection. No other treatments, such as immunosuppression, were administered to avoid risk of infection. Following a complicated hospital course, the patient restarted oral intake after 6 months of total parenteral nutrition dependency. Her abdominal fistula resolved completely, and she was maintained on hemodialysis for few years before she received a kidney transplant.

CONCLUSION

When treating patients using peritoneal dialysis, it is important to consider encapsulating peritoneal sclerosis with refractory peritonitis, which is not always easy to identify, particularly if the patient has been maintained on peritoneal dialysis for less than 3 years. Early identification of encapsulating peritoneal sclerosis and appropriate conservative treatment, including nutritional optimization and treatment of infections, are essential to achieve a better prognosis.

摘要

背景

包裹性腹膜硬化症是一种罕见但潜在致命的长期腹膜透析并发症,与显著的发病率和死亡率相关。包裹性腹膜硬化症的发生在全球范围内有所不同,但在接受腹膜透析治疗 5-8 年的患者中更为常见。包裹性腹膜硬化症的病因仍未确定,需要高度的临床怀疑才能做出诊断。

病例介绍

我们报告了一名 5 岁的沙特女性,患有 2 型肾单位肾痨继发的终末期肾病。她接受了 30 个月的腹膜透析治疗,发生了 4 次腹膜炎。她出现了腹膜炎的临床症状。3 天后,她发生了感染性休克,需要入住儿科重症监护病房。由于难治性腹膜炎,腹膜透析导管被移除。她的病程还并发了小肠穿孔,腹部超声和计算机断层扫描显示严重粘连,符合包裹性腹膜硬化症的诊断。这一发现后来通过两次诊断性剖腹手术得到证实,并并发复发性腹壁瘘。她接受了 6 个月的全胃肠外营养和多次抗生素疗程。患者接受了支持性治疗,包括营养优化和感染治疗。为了避免感染风险,没有给予其他治疗,如免疫抑制治疗。在经历了复杂的住院治疗后,患者在全胃肠外营养依赖 6 个月后开始恢复口服饮食。她的腹壁瘘完全愈合,在接受肾移植之前,她接受了数年的血液透析治疗。

结论

在使用腹膜透析治疗患者时,对于难治性腹膜炎伴有包裹性腹膜硬化症的患者,需要考虑到这一点,因为这并不总是容易识别,尤其是如果患者接受腹膜透析治疗的时间不足 3 年。早期识别包裹性腹膜硬化症并进行适当的保守治疗,包括营养优化和感染治疗,对于获得更好的预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb8/8276428/4a825e596a03/13256_2021_2905_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验